U.S. Markets
AbbVie (ABBV) exec now expects total annual net revenue of approximately USD 67.6bln, increase of USD 300mln vs. previous forecast
StockNow breaking-news AI analysis
AbbVie raised its 2026 revenue forecast to $67.6 billion following strong Q2 sales, but lowered EPS guidance due to the $10.9 billion Apogee acquisition, causing shares to decline.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
